Journal Watch
Thrombotic microangiopathies
Atypical Hemolytic Uremic Syndrome: New Challenges in the Complement Blockage Era.
Author(s): Avila Bernabeu AI, Cavero Escribano T, Cao Vilarino M Source: Nephron 2020;144(11):537-549 Publication date: 2020
Thrombotic microangiopathy: COVID-19 or hydroxychloroquine?
Author(s): Hasbal NB Source: Kidney Int 2020 Dec;98(6):1619-1620 Publication date: 2020-12
Thrombotic microangiopathy and their mimickers.
Author(s): Palma LMP, Sethi S Source: Nephrol Dial Transplant 2020 Sep 23; Publication date: 2020-09-23
Eculizumab, SARS-CoV-2 and atypical hemolytic uremic syndrome.
Author(s): Trimarchi H, Gianserra R, Lampo M, Monkowski M, Lodolo J Source: Clin Kidney J 2020 Oct;13(5):739-741 Publication date: 2020-10
Validation of Early Increase in Complement Activation Marker sC5b-9 as a Predictive Biomarker for the Development of Thrombotic Microangiopathy After Stem Cell Transplantation.
Author(s): Mezö B, Horváth O, Sinkovits G, Veszeli N, Kriván G, Prohászka Z Source: Front Med (Lausanne) 2020;7:569291 Publication date: 2020 |